Purchase Order 75N91022P00832

This is a $176,252.54 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services (HHS), to Battelle Memorial Institute. The contract is for the evaluation of human tissue cross-reactivity of Phase I clinical trial serum samples containing antibodies elicited by a multivalent Group A Streptococcal vaccine. The contract does not have a set-aside designation. Battelle has...

This firm fixed-price purchase order was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Battelle Memorial Institute, doing business as Battelle, for $3,977,119. The objective is to explore immune correlates of protection in rhesus macaques administered various SARS-CoV-2 vaccine candidates designed by Moderna, Novavax, Janssen and Sanofi Pasteur. Battelle will conduct the study under an approved quality management plan...

This cost-plus-fixed-fee delivery order from the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Battelle Memorial Institute is for $7.59 million to support preparedness for testing NIAID priority vaccines in general safety and toxicology studies. The work includes Chinese cynomolgus non-human primate testing and transportation from Envigo Global Services, procurement of ferrets from Triple F Farms, and...

This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) worth up to $146,300,000 with Pennsylvania State University (Penn State) for the development and use of animal and animal replacement models to evaluate therapeutics, vaccines, and diagnostics against infectious diseases. The specific task order, valued at $1,232,512, is to test candidate therapeutics...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Battelle Memorial Institute on July 30, 2019, for immunogenicity and efficacy testing of medical countermeasures (vaccines and other biologics) against BSL-4 pathogens in non-human primates, with a ceiling value of $20.8 million and ultimate completion date of December 14, 2027. This is a delivery order under Battelle's Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious...

This contract was awarded by the Department of Defense Uniformed Services University of the Health Sciences to Spring Valley Laboratories, Inc. (DBA SVL), a self-certified small disadvantaged business. The contract is for a Firm Fixed Price Blanket Purchase Agreement (BPA) Call to conduct an immunization study on rabbits (GP350MT SQ IMMUNIZATION STUDY ON RABBITS). The potential value of the contract is $4,662.92, and the period of performance runs through December 19, 2016. No set-aside...

This is a $4,626,893.20 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Battelle Memorial Institute. The contract is for the evaluation of filovirus vaccines in general use prophylaxis (GUP) immunogenicity and filovirus challenge studies. Key subcontractors include Integrated Biotherapeutics, LLC, a small disadvantaged business, which provided services related to filovirus...

Genscript USA Inc. was awarded a $172,800 firm fixed price blanket purchase agreement call contract by the Department of Agriculture Animal and Plant Health Inspection Service Wildlife Services to provide SARS-COV-2 surrogate virus neutralization testing. The testing will support Wildlife Services' research and development efforts through June 2023. No set-aside provisions were applied to this contract awarded under the agency's SARS-COV-2 surrogate virus neutralization test blanket purchase...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Battelle Memorial Institute, a large nonprofit research and development organization. The contract, valued at $6,398,512.00, is for clinical sample testing of SARS-CoV-2 vaccine candidates. This is a cost-plus-fixed-fee type contract that will run through April 17, 2025. The contract has several subcontractors, including Integral...

This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. for the manufacture and safety testing of experimental virus vaccines. The $174,106.10 firm fixed-price delivery order does not have a set-aside designation. Charles River Laboratories is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development...